These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 23693151)
1. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents. Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents. Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685 [TBL] [Abstract][Full Text] [Related]
3. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation. Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386 [TBL] [Abstract][Full Text] [Related]
4. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity. Shi JB; Tang WJ; Qi XB; Li R; Liu XH Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents. Al-Tel TH Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol. Malki A; Laha R; Bergmeier SC Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475 [TBL] [Abstract][Full Text] [Related]
8. A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents. Wang X; Pan YM; Huang XC; Mao ZY; Wang HS Org Biomol Chem; 2014 Apr; 12(13):2028-32. PubMed ID: 24519368 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents. Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity. Özdemir A; Altıntop MD; Kaplancıklı ZA; Turan-Zitouni G; Ciftçi GA; Yıldırım SU J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1221-7. PubMed ID: 23020635 [TBL] [Abstract][Full Text] [Related]
11. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis. Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents. Insuasty B; Montoya A; Becerra D; Quiroga J; Abonia R; Robledo S; Vélez ID; Upegui Y; Nogueras M; Cobo J Eur J Med Chem; 2013 Sep; 67():252-62. PubMed ID: 23871905 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity. Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and Qi XX; Wang PP; Cui LT; Jin M; Zhao LX; Li G J Asian Nat Prod Res; 2024 Jul; 26(7):812-823. PubMed ID: 38477295 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives. Fan NJ; Tang JJ; Li H; Li XJ; Luo B; Gao JM Eur J Med Chem; 2013 Nov; 69():182-90. PubMed ID: 24021891 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827 [TBL] [Abstract][Full Text] [Related]
18. Stereoselective synthesis of 15- and 16-substituted isosteviol derivatives and their cytotoxic activities. Wu Y; Dai GF; Yang JH; Zhang YX; Zhu Y; Tao JC Bioorg Med Chem Lett; 2009 Mar; 19(6):1818-21. PubMed ID: 19223180 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas. Comes Franchini M; Bonini BF; Camaggi CM; Gentili D; Pession A; Rani M; Strocchi E Eur J Med Chem; 2010 May; 45(5):2024-33. PubMed ID: 20129719 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, cytotoxic activity evaluation and HQSAR study of novel isosteviol derivatives as potential anticancer agents. Liu CJ; Yu SL; Liu YP; Dai XJ; Wu Y; Li RJ; Tao JC Eur J Med Chem; 2016 Jun; 115():26-40. PubMed ID: 26994841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]